Important: By clicking “Yes” you are confirming that you are a healthcare professional. OncosilTM is currently unapproved for commercial sale in your region. If you are not a healthcare professional then please click here to Go to the Homepage.
Each patient receives a patient-specific dose of OncoSil™ which is calculated according to the patient’s tumour size. This dose is prepared within the Nuclear Medicine Department of the implanting centre or within a licensed Radiopharmacy. Only appropriately licensed personnel, who have been trained in the preparation of OncoSil™ doses may prepare the product for implantation. The OncoSil™ implantation procedure is performed in a suitable institution environment by a suitably qualified Endoscopist and the Oncosil trained Authorised User
The procedure is conducted using Endoscopic Ultrasound (EUS) Guidance. An EUS guided FNA needle is loaded through the biopsy channel of the echoendoscope and slowly advanced through the gastric wall or duodenal wall into the target pancreatic tumour.
Once the needle is positioned inside the tumour, the syringe containing the dose is attached and the required amount of OncoSil™ suspension is then implanted manually by slowly depressing the plunger.Once the dose of OncoSil™ has been implanted into the tumour, the needle assembly is removed.